Current through Register Vol. 39, No. 6, September 16, 2024
(a) The prescribing
stipulations contained in this Rule apply to writing prescriptions and ordering
the administration of medications.
(b) Prescribing and dispensing stipulations
are as follows:
(1) Drugs and devices that
may be prescribed by the nurse practitioner in each practice site shall be
included in the collaborative practice agreement as outlined in Rule .0110(2)
of this Section.
(2) Controlled
Substances (Schedules II, IIN, III, IIIN, IV, V) defined by the State and
Federal Controlled Substances Acts may be procured, prescribed, or ordered as
established in the collaborative practice agreement, providing all of the
following requirements are met:
(A) the nurse
practitioner has an assigned DEA number that is entered on each prescription
for a controlled substance;
(B)
refills may be issued consistent with Controlled Substance laws and
regulations; and
(C) the primary
supervising physician(s) shall possess a schedule(s) of controlled substances
equal to or greater than the nurse practitioner's DEA registration.
(3) The nurse practitioner may
prescribe a drug or device not included in the collaborative practice agreement
only as follows:
(A) upon a specific written
or verbal order obtained from a primary or back-up supervising physician before
the prescription or order is issued by the nurse practitioner; and
(B) the written or verbal order as described
in Part (b)(3)(A) of this Rule shall be entered into the patient record with a
notation that it is issued on the specific order of a primary or back-up
supervising physician and signed by the nurse practitioner and the
physician.
(4) Each
prescription shall be noted on the patient's chart and include the following
information:
(A) medication and
dosage;
(B) amount
prescribed;
(C) directions for
use;
(D) number of refills;
and
(E) signature of nurse
practitioner.
(5)
Prescription Format:
(A) All prescriptions
issued by the nurse practitioner shall contain the name of the patient and the
nurse practitioner's name and telephone number;
(B) The nurse practitioner's assigned DEA
number shall be written on the prescription form when a controlled substance is
prescribed as defined in Subparagraph (b)(2) of this Rule.
(6) A nurse practitioner shall not prescribe
controlled substances, as defined by the State and Federal Controlled
Substances Acts, for the following:
(A) nurse
practitioner's own use;
(B) nurse
practitioner's supervising physician;
(C) a member of the nurse practitioner's
immediate family, which shall mean a:
(i)
spouse;
(ii) parent;
(iii) child;
(iv) sibling;
(v) parent-in-law;
(vi) son or daughter-in-law;
(vii) brother or sister-in-law;
(viii) step-parent;
(ix) step-child; or
(x) step-siblings;
(D) any other person living in the same
residence as the licensee; or
(E)
anyone with whom the nurse practitioner is having a physical, sexual, or
emotionally intimate relationship.
(c) The nurse practitioner may obtain
approval to dispense the drugs and devices other than samples included in the
collaborative practice agreement for each practice site from the Board of
Pharmacy, and dispense in accordance with
21 NCAC
46 .1703 that is hereby incorporated by
reference including subsequent amendments.
